We thank Drs David Buchner, M. Elaine Cress and Lawrence H. Larsen, Suzanne Barsness, Jane Corkery Hahn, Gwen Drolet, Steve Gait, Rebecca Green, Robert Hastings, Monica Kletke, Erin Madar, Ken Trimm, Robert Ward, Danielle Yancey, and the staff of the University of Washington General Clinical Research Center for their expert assistance. We thank Serono Laboratories Inc for providing

GHRH (sermorelin Inhibitors,research,lifescience,medical acetate, Geref) and placebo. Contributor Information Michael V. Vitiello, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Wash. Robert S. Schwartz, Department of Medicine, University of Colorado, Denver, Co. Karen E. Moe, Department of Psychiatry and Behavioral Sciences, University of Washington, Inhibitors,research,lifescience,medical Seattle, Wash. Giuliana Mazzoni, Department of Psychology, Seton Hall University, South Orange, NJ, USA. George R. Merriam, Department of Medicine, University of Washington, Seattle, Wash; Veterans Affairs Puget Sound Health Care System, Seattle, Wash.
A prominent feature

of the current, and projected populations in developed and developing countries is the increase in the relative and absolute numbers of aging Inhibitors,research,lifescience,medical individuals (Figure 1). 1 Defined by various organizations as those over age 60, or alternatively 65, this heterogeneous population is estimated by the World Health Organization to increase to ewer one billion worldwide by the year 2020.2 Europe is expected to increase its percentage of aged residents from its current 20% to 25%. rIli c population of Japan is expected to be over 30% aged. Projections for North America, East Asia, Latin America, and South Asia Inhibitors,research,lifescience,medical are 23%, 17%, 12%, and 10%, respectively.2 The most rapid increases are expected in developing countries. Whereas France increased its aged population from 7% to 17% ewer the course of 115 years (1865-1980), estimates are that China will double its number in the same demographic group from 10% to 20% in the 20 years between 2000 and 2027.2 Causes of death in developing countries are expected to be largely age-related by 2020, coming from

noncommunicable diseases such as cancer, diabetes, and cardiovascular disease,2 Inhibitors,research,lifescience,medical conditions which have been heavily dependent on drug therapy for management, in developed countries. Figure 1. Actual and projected demographic data from the US population’ shown as a representative example of cross-national demographic shifts. Ciosed circles connected by solid lines are the actual numbers Florfenicol of individuals aged 65 years or older, with anticipated … In addition, the number of individuals over age 85 will rise PD98059 cell line dramatically The US government expects these “oldest of the old” to grow by 56% to 5.7 million between 1995 and 2010, as compared with the 13% increase in those aged 65 to 84.3 Projections are that the cumulative growth rate for this particular “oldest” subset from 1995 to 2050 will be greater than 400%, constituting nearly 5% of the total US population.